Abstract
Chronic hepatitis C virus infection has previously been shown to be associated in some cases with an immunologic disorder called "Essential Mixed Cryoglobulinemia" (EMC). In this report a case of transfusion-associated chronic hepatitis C will be demonstrated. During patient's follow-up over a period of fifteen years the woman developed symptoms consistent with the clinical triad of EMC: general weakness, polyarthralgias and purpura. Laboratory chemical values support the presence of mixed cryoglobulins. Application of different therapeutic strategies revealed an improvement of both clinical and biochemical findings during interferon-alpha treatment. Results suggest that during chronic hepatitis C virus infection interferon-alpha therapy may represent the elective choice of treatment for typical symptoms of EMC.
MeSH terms
-
Biopsy
-
Blood Transfusion
-
Combined Modality Therapy
-
Cryoglobulinemia / immunology
-
Cryoglobulinemia / pathology
-
Cryoglobulinemia / therapy*
-
Cryoglobulins / metabolism
-
Female
-
Hepatitis C / immunology
-
Hepatitis C / pathology
-
Hepatitis C / therapy*
-
Hepatitis C / transmission
-
Hepatitis, Chronic / immunology
-
Hepatitis, Chronic / pathology
-
Hepatitis, Chronic / therapy*
-
Humans
-
Hysterectomy
-
Immunoglobulin Light Chains / blood
-
Immunoglobulin M / blood
-
Interferon-alpha / administration & dosage*
-
Liver / pathology
-
Liver Function Tests
-
Middle Aged
-
Postoperative Complications / immunology
-
Postoperative Complications / pathology
-
Postoperative Complications / therapy
-
Recurrence
-
Rheumatoid Factor / blood
-
Skin / pathology
Substances
-
Cryoglobulins
-
Immunoglobulin Light Chains
-
Immunoglobulin M
-
Interferon-alpha
-
Rheumatoid Factor